Ignite Creation Date:
2025-12-25 @ 2:27 AM
Ignite Modification Date:
2026-04-21 @ 9:56 PM
Study NCT ID:
NCT03414034
Status:
COMPLETED
Last Update Posted:
2024-11-07
First Post:
2018-01-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Onvansertib in Combination With Abiraterone and Prednisone in Adult Patients With Metastatic Castration-Resistant Prostate Cancer
Sponsor:
Cardiff Oncology
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
TROV-053
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None